0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Percutaneous vertebral augmentation—pearls and pitfalls

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Percutaneous vertebral augmentation (PVA) procedures, such as vertebroplasty and kyphoplasty, are commonly utilized surgical approaches mainly indicated for treatment of osteoporotic vertebral fractures, multiple myeloma and osteolytic metastatic lesions. First described by Galibert et al. in 1987 (1), continued evolution of techniques and materials has resulted in a notable improvement in terms of safety and effectiveness (2,3). However, the first two randomized controlled trials published in 2019 comparing vertebroplasty with a sham procedure showed no differences in terms of pain and quality of life at one week or at one, three, or six months after treatment, with only a trend towards a higher rate of clinically improvement in pain in the vertebroplasty group (4,5). Based on this, guidelines initially did not recommend the use of vertebroplasty and kyphoplasty as an option for the management of painful osteoporotic compression fractures (6). However, since then, many more randomized controlled trials have been published, with all but one reporting the superiority of vertebral augmentation compared with optimal medical management in terms of pain scores and quality of life (7-12). The mechanism of pain relief associated with PVA has not been fully elucidated. It appears that restoration of the vertebral height is a crucial step for maintenance of the sagittal balance, thus decreasing the efforts generated by the paraspinal muscles (13,14). Moreover, restoration of vertebral rigidity and load-bearing capacity is thought to reduce painful micromotion (15,16). In terms of surgical technique, PVA is usually a safe procedure, with pitfalls that can be avoided with a strict observation of several principles and, most importantly, careful patient selection. PVA is strongly indicated in patients describing a focal, intense, deep pain in the midline of the spine. This pain should be mechanical, meaning worse while standing and better with recumbency (17). Magnetic resonance imaging (MRI) of the spine is useful to identify the acute and subacute fractures that usually respond well to PVA. Acute fractures demonstrate edema as decreased T1 and increased T2 or short-inversion-time inversion recovery (STIR) sequence signals (18). MRI may also differentiate osteoporotic fractures from pathologic fractures that result from metastasis or infection. A number of concerns regarding PVA should be mentioned. First of all, the risk of cement extravasation is higher in patients with cortical disruption or preexisting radicular complaints; these cases should be treated with alternative procedures (19). PVA are also technically challenging in cases of vertebra plana, loss of more than 66% of vertebral height or fractured bodies inferior to the pedicle (20). During the procedure, several important steps should be adhered to. First of all, true lateral and antero-posterior views should be obtained and images should be frequently checked to have a real-time and constant control of the trajectory. Care should be taken not to pierce the anterior cortex of the vertebra to reduce the risk of extravasation. Furthermore, cement should be of adequate consistency before it is injected to minimize the risk of leak through the fissures or into the venous sinuses. A recent study by Nogami et al. (21) , which is published in Journal of Spine Surgery describe a case of T12 and L1 percutaneous kyphoplasty for osteoporotic vertebral fracture, complicated by post-operative loss of sensation and strength in the lower extremities. Imaging demonstrated an intradural hematoma and a fracture line in the medial cortex of the right pedicle at T12. Emergency decompression was performed with good clinical recovery. The important experience of Nogami et al. highlights one of the critical points of the PVA procedure which is the insertion of the Jamshidi needle into the pedicle. This step is often more challenging when approaching small pedicles, such as those found in the thoracic vertebrae. It is important to avoid medial direction which can fracture the pedicle causing cement extravasation and neurovascular injury. The study also highlights the potential role of CT-based or robot-assisted navigation with the purpose of preventing complications. Zhang et al. (22), in a recent meta-analysis and review, state that robot-assisted percutaneous vertebral augmentation (RA-PVA) is more accurate in determining the ideal needle entry-point, leading to increased safety and lower rates cement leakage. Furthermore, fluoroscopy-assisted percutaneous vertebral augmentation (FA-PVA) may require more fluoroscopy time and multiple punctures, possibly determining further damage to the fragile vertebral body, thus increasing the chance of procedure failure. Another important aspect assessed in this study is the length of surgery which seemed to be similar in both type of procedures. Being robot-assisted navigation a new technological tool, it could be possible to hypothesize that surgeons will become more confident with time, with shorten of the length of surgery compared to FA-PVA. Interestingly, clinical outcome reported using VAS (Visual Analog Score) and ODI (Oswestry Disability Index) had similar results (23). In conclusion, although prospective data establishing the merits of PVA over nonoperative treatment are still lacking, PVA has proved to be a safe and effective procedure that should be recommended only in patient with specific clinical and radiological features. Aside the risk of procedure failure in terms of pain control, the most inconvenient scenario is represented by procedural complications. The most common of whose is the cement extravasation. Indeed, robot-assisted percutaneous vertebral augmentation is a potentially interesting and useful tool that could improve safety and outcomes. Further data and studies need be conducted to assess its real effectiveness, evaluating benefit-cost balance. Moreover, it is important to underline the fact that surgeon’s role remains essential for the success of the procedure, regardless the technology and the technique used. Indications, unexpected intraoperative findings, and anatomical variants cannot be examined by any robot or navigation system, and the surgeon remains the main responsible to guide each case toward the success. The case report and literature review by Nogami et al. serve as an important reminder on maintaining safe principles during procedures such as percutaneous kyphoplasty. Supplementary The article’s supplementary files as 10.21037/jss-22-106

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.

          Vertebroplasty has become a common treatment for painful osteoporotic vertebral fractures, but there is limited evidence to support its use. We performed a multicenter, randomized, double-blind, placebo-controlled trial in which participants with one or two painful osteoporotic vertebral fractures that were of less than 12 months' duration and unhealed, as confirmed by magnetic resonance imaging, were randomly assigned to undergo vertebroplasty or a sham procedure. Participants were stratified according to treatment center, sex, and duration of symptoms ( or = 6 weeks). Outcomes were assessed at 1 week and at 1, 3, and 6 months. The primary outcome was overall pain (on a scale of 0 to 10, with 10 being the maximum imaginable pain) at 3 months. A total of 78 participants were enrolled, and 71 (35 of 38 in the vertebroplasty group and 36 of 40 in the placebo group) completed the 6-month follow-up (91%). Vertebroplasty did not result in a significant advantage in any measured outcome at any time point. There were significant reductions in overall pain in both study groups at each follow-up assessment. At 3 months, the mean (+/-SD) reductions in the score for pain in the vertebroplasty and control groups were 2.6+/-2.9 and 1.9+/-3.3, respectively (adjusted between-group difference, 0.6; 95% confidence interval, -0.7 to 1.8). Similar improvements were seen in both groups with respect to pain at night and at rest, physical functioning, quality of life, and perceived improvement. Seven incident vertebral fractures (three in the vertebroplasty group and four in the placebo group) occurred during the 6-month follow-up period. We found no beneficial effect of vertebroplasty as compared with a sham procedure in patients with painful osteoporotic vertebral fractures, at 1 week or at 1, 3, or 6 months after treatment. (Australian New Zealand Clinical Trials Registry number, ACTRN012605000079640.) 2009 Massachusetts Medical Society
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A randomized trial of vertebroplasty for osteoporotic spinal fractures.

            Vertebroplasty is commonly used to treat painful, osteoporotic vertebral compression fractures. In this multicenter trial, we randomly assigned 131 patients who had one to three painful osteoporotic vertebral compression fractures to undergo either vertebroplasty or a simulated procedure without cement (control group). The primary outcomes were scores on the modified Roland-Morris Disability Questionnaire (RDQ) (on a scale of 0 to 23, with higher scores indicating greater disability) and patients' ratings of average pain intensity during the preceding 24 hours at 1 month (on a scale of 0 to 10, with higher scores indicating more severe pain). Patients were allowed to cross over to the other study group after 1 month. All patients underwent the assigned intervention (68 vertebroplasties and 63 simulated procedures). The baseline characteristics were similar in the two groups. At 1 month, there was no significant difference between the vertebroplasty group and the control group in either the RDQ score (difference, 0.7; 95% confidence interval [CI], -1.3 to 2.8; P=0.49) or the pain rating (difference, 0.7; 95% CI, -0.3 to 1.7; P=0.19). Both groups had immediate improvement in disability and pain scores after the intervention. Although the two groups did not differ significantly on any secondary outcome measure at 1 month, there was a trend toward a higher rate of clinically meaningful improvement in pain (a 30% decrease from baseline) in the vertebroplasty group (64% vs. 48%, P=0.06). At 3 months, there was a higher crossover rate in the control group than in the vertebroplasty group (51% vs. 13%, P<0.001) [corrected]. There was one serious adverse event in each group. Improvements in pain and pain-related disability associated with osteoporotic compression fractures in patients treated with vertebroplasty were similar to the improvements in a control group. (ClinicalTrials.gov number, NCT00068822.) 2009 Massachusetts Medical Society
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              [Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty].

              Findings in several cases are used to demonstrate that certain vertebral angiomas may not be congenital and can ultimately provoke medullary or radicular neurologic complications. Radiotherapy is the usual treatment but is not always accepted unconditionally close to spinal cord. Destruction of angioma and consolidation of vertebral column can be obtained by percutaneous intrasomatic injection of acrylic cement. The preoperative radiologic examination includes direct phlebography with insertion of trocar, the vertebroplasty being performed under television screen surveillance. Results in seven patients treated are very encouraging but the current 2-year follow up requires extension. However, the method appears to be able to be included amongst treatment for an affection of sometimes seriously questioned benign nature.
                Bookmark

                Author and article information

                Journal
                J Spine Surg
                J Spine Surg
                JSS
                Journal of Spine Surgery
                AME Publishing Company
                2414-469X
                2414-4630
                07 February 2023
                30 March 2023
                : 9
                : 1
                : 13-16
                Affiliations
                [1 ]deptDivision of Neurosurgery, Policlinico Universitario “G. Martino” , Universita’ degli Studi di Messina , Messina, Italy;
                [2 ]deptDivision of Neurosurgery, Sunnybrook Health Sciences Centre , University of Toronto , Toronto, ON, Canada;
                [3 ]deptDivision of Neurosurgery, Health Sciences North , Northern Ontario School of Medicine University , Sudbury, ON, Canada;
                [4 ]deptDivision of Neurology, Health Sciences North , Northern Ontario School of Medicine University , Sudbury, ON, Canada;
                [5 ]deptDepartment of Pathology, Stanford of School of Medicine , Stanford University Medical Centre, Stanford , Palo Alto, CA, USA
                Author notes
                Correspondence to: Stefano M. Priola. Division of Neurosurgery, Health Sciences North, Northern Ontario School of Medicine University, Sudbury (ON), Canada. Email: spriola@ 123456nosm.ca .
                [^]

                ORCID: 0000-0002-5153-6230.

                Article
                jss-09-01-13
                10.21037/jss-22-106
                10082425
                fbc7cef7-80a9-41e3-a886-0f42d17cf2ba
                2023 Journal of Spine Surgery. All rights reserved.

                Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

                History
                : 28 November 2022
                : 03 January 2023
                Categories
                Editorial

                percutaneous vertebral augmentation procedure,kyphoplasty,vertebroplasty,subarachnoid hemorrhage

                Comments

                Comment on this article